New York State Common Retirement Fund
VRCA icon

New York State Common Retirement Fund’s Verrica Pharmaceuticals VRCA Stock Holding History

New York State Common Retirement Fund’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-908
Closed -$4.01K – 3351
2025
Q1 		$4.01K Hold
908
– – ﹤0.01% 3135
2024
Q4 		$6.35K Hold
908
– – ﹤0.01% 3136
2024
Q3 		$13.2K Hold
908
– – ﹤0.01% 3085
2024
Q2 		$66.2K Sell
908
-69
-7% -$5.3K ﹤0.01% 3018
2024
Q1 		$57.8K Buy
977
+69
+8% +$3.81K ﹤0.01% 2941
2023
Q4 		$66.5K Sell
908
-4
-0.4% -$164 ﹤0.01% 2912
2023
Q3 		$35.4K Sell
912
-728
-44% -$37K ﹤0.01% 3102
2023
Q2 		$94.6K Buy
+1,640
New +$99.6K ﹤0.01% 2897
2022
Q3 		– Sell
-13
Closed – – 3460
2022
Q2 		$0 Sell
13
-811
-98% -$40.8K ﹤0.01% 3544
2022
Q1 		$67K Hold
824
– – ﹤0.01% 3106
2021
Q4 		$75K Hold
824
– – ﹤0.01% 3147
2021
Q3 		$103K Buy
824
+2
+0.2% +$224 ﹤0.01% 3132
2021
Q2 		$93K Buy
822
+11
+1% +$1.33K ﹤0.01% 3219
2021
Q1 		$123K Buy
811
+341
+73% +$47.2K ﹤0.01% 3000
2020
Q4 		$54K Hold
470
– – ﹤0.01% 3178
2020
Q3 		$36K Sell
470
-910
-66% -$74.5K ﹤0.01% 3175
2020
Q2 		$152K Hold
1,380
– – ﹤0.01% 2777
2020
Q1 		$151K Hold
1,380
– – ﹤0.01% 2596
2019
Q4 		$219K Hold
1,380
– – ﹤0.01% 2699
2019
Q3 		$204K Hold
1,380
– – ﹤0.01% 2761
2019
Q2 		$160K Buy
1,380
+1,040
+306% +$97.6K ﹤0.01% 2932
2019
Q1 		$37K Hold
340
– – ﹤0.01% 3100
2018
Q4 		$28K Buy
+340
New +$41.3K ﹤0.01% 3138

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York State Common Retirement Fund's VRCA Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 908 shares — an estimated $4.01K sold.

New York State Common Retirement Fund first reported a position in VRCA in Q4 2018 and held it in 23 quarters. The position peaked at $219K in Q4 2019. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 908 Verrica Pharmaceuticals shares in Q2 2025, an estimated $4.01K.
  • New York State Common Retirement Fund first reported a position in Verrica Pharmaceuticals in Q4 2018 and held it in 23 quarters.
  • New York State Common Retirement Fund's Verrica Pharmaceuticals position peaked at $219K in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.